Earnings Feed
Start Free
Home/Filings/4/0001179110-12-012723
4//SEC Filing

KOENIG DAVID 4

Accession 0001179110-12-012723

CIK 0001222244other
View on SEC.govCompany Profile

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 3:49 PM ET

Size

14.5 KB

Accession

0001179110-12-012723

Insider Transaction Report

Form 4
Period: 2012-08-09
ProUroCare Medical Inc.PUMD
KOENIG DAVID
Director
Transactions
  • Award

    Stock Options

    2012-08-09+25,000→ 25,000 total
    Exercise: $0.60Exp: 2019-08-09→ Common stock, $0.00001 par value (25,000 underlying)
Holdings

  • Common Stock, $0.00001 par value

    (indirect: Shares held by Clinical Network Management Corp., of which reporting person is a managing officer.)
    1,875

  • Warrants

    Exercise: $1.30Exp: 2013-08-02→ Common stock, $0.00001 par value (50,000 underlying)
    50,000

  • Convertible Note

    Exercise: $1.10Exp: 2012-08-28→ Common stock, $0.00001 par value

  • Common Stock, $0.00001 par value

    (indirect: Shares held by Clinical Network Inc., of which the reporting person is a managing officer.)
    26,571

  • Stock options

    Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (50,000 underlying)
    50,000

  • Stock Options

    Exercise: $1.72Exp: 2017-08-10→ Common stock, $0.00001 par value (14,535 underlying)
    14,535

  • Common stock, $0.00001 par value

    188,324

  • Stock options

    Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying)
    28,736
Footnotes (3)
  • [F1]Currently exercisable.
  • [F2]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
  • [F3]On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $6,400 with a maturity date of February 28, 2012. The maturity date was subsequently changed to August 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).

Documents

1 file

Issuer

ProUroCare Medical Inc.

CIK 0001222244

→
Entity typeother

Related Parties

1
  • filerCIK 0001285927

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 3:49 PM ET
Size
14.5 KB
View on SEC.gov